Cargando…
Exploring the diversity of blood microbiome during liver diseases: Unveiling Novel diagnostic and therapeutic Avenues
Liver diseases are a group of major metabolic and immune or inflammation related diseases caused due to various reasons including infection, abnormalities in immune system, genetic defects, and lifestyle habits. However, the cause-effect relationship is not completely understood in liver disease. Th...
Autores principales: | Vasudevan, Dinakaran, Ramakrishnan, Arulraj, Velmurugan, Ganesan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638009/ https://www.ncbi.nlm.nih.gov/pubmed/37954280 http://dx.doi.org/10.1016/j.heliyon.2023.e21662 |
Ejemplares similares
-
Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study
por: Ramakrishnan, Arulraj, et al.
Publicado: (2022) -
Metagenomic analysis of RNA sequencing data reveals SARS-CoV-2-mediated progressive dysbiosis of upper respiratory tract microbiota
por: Velmurugan, Ganesan, et al.
Publicado: (2021) -
Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment
por: Singh, Shilpi, et al.
Publicado: (2023) -
The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
por: Kirby, Trevor O., et al.
Publicado: (2018) -
Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective
por: Munteanu, Raluca, et al.
Publicado: (2023)